Clinical Trial Update: Mapping B-cell Biology Across the Cardiovascular Territories of Giant Cell Arteritis: Towards a New Therapeutic Approach (RituxiMAP GCA)

View source ↗

Summary

A clinical trial update describing RituxiMAP GCA, a study to map B-cell biology in Giant Cell Arteritis to identify a new therapeutic approach; the study is not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giant Cell Arteritis

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: University of Edinburgh | Conditions: Giant Cell Arteritis (GCA) | Status: NOT_YET_RECRUITING